"Please Note: Due to the COVID-19 virus some locations have moved. Please contact your doctor's office to confirm the address. BMC is restricting all visitors unless pre-approved by each patient's care team under extenuating circumstances. Medical Clinic"

During the past decade, Boston Medical Center, Department of Vascular Surgery conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Boston Medical Center, Department of Vascular Surgery" are "Leg Ulcer" (1 trials) and "Venous Leg Ulcer" (1 trials). Many other conditions were trialed in "Boston Medical Center, Department of Vascular Surgery" in a lesser frequency.

Most popular intervention types in "Boston Medical Center, Department of Vascular Surgery" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dermagraft(R)" (1 trials), "ICXP007" (1 trials) and "Profore" (1 trials). Other intervention names were less common.

The vast majority of trials in "Boston Medical Center, Department of Vascular Surgery" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Boston Medical Center, Department of Vascular Surgery". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Boston Medical Center, Department of Vascular Surgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Boston Medical Center, Department of Vascular Surgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".